Research Paper Volume 15, Issue 24 pp 14900—14914

Acetylshikonin induces necroptosis via the RIPK1/RIPK3-dependent pathway in lung cancer

class="figure-viewer-img"

Figure 3. Acetylshikonin increased the membrane permeability of NSCLC cells and the proportion of necrotic NSCLC cells. (A, B) Flow cytometry results for Annexin V/PI showing the incidence of cell death among H1299 and A549 cells following treatment with acetylshikonin (0.5–10 μM) for 24 h (n = 4). (C) Phase microscope images of NSCLC cells following incubation with acetylshikonin (0.5–10 μM) for 24 h. Red arrows indicate swollen blebs. Scale bar = 50 μm. (D, E) PI staining results of H1299 and A549 cells following treatment with acetylshikonin (0.5–10 μM) for 4 h. Scale bar = 200 μm. Untreated cells were used as controls. Results are shown as means ± SD. *p < 0.05 compared to untreated control.